Bavarian Nordic — August 2023
-
Bavarian efter succesrigt fase 3-studie: Håber på lancering af chikungunya-vaccine i 2025 https://www.proinvestor.com/investornyt/1029400/bavarian-efter-succesrigt-fase-3-studie-haber-pa-lancering-af-chikungunya-vaccine-i-2025
-
En aktie, der har en forventet P/E i år på langt under 10 - skal komme op på et tidspunkt. Jeg tror Mpox er ongoing fremover. Det er ikke slut efter 2024!. Enig i at den manipuleres af hedgefonde - men en dag er nok slut. Men vi tror nok alle på noget forskelligt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind